23andMe faces class action lawsuit in California

December 3, 2013

Genetic testing company 23andMe is facing a class action lawsuit alleging that the Silicon Valley startup misled customers about its test kit.

The test is promoted as helping predict users' disease risk based on their DNA.

The lawsuit, filed in U.S. district court in California last week, comes days after the Food and Drug Administration ordered 23andMe to halt sales of its personalized test, saying the company failed to show that the technology is supported by science.

23andMe sells its $99 test online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.

The lawsuit by San Diego resident Lisa Casey alleges that the test results are "meaningless."

23andMe said Tuesday that it would not comment on legal matters.

Explore further: 23andMe identifies 5 significant genetic associations for hypothyroidism

Related Stories

US tells 23andMe to halt sales of genetic test

November 25, 2013

The U.S. Food and Drug Administration is ordering genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is backed by science.

It is game over for 23andMe, and rightly so

November 27, 2013

The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone out of business. Now, ...

Recommended for you

New genetic syndrome tied to defects in protein transport

July 28, 2016

An international team of researchers has discovered the mutation responsible for a rare, newly identified genetic disorder that causes craniofacial abnormalities and developmental delays. The mutation disrupts normal protein ...

New genetic clues into motor neuron disease

July 26, 2016

Researchers at The University of Queensland have contributed to the discovery of three new genes which increase the risk of motor neuron disease (MND), opening the door for targeted treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.